Jian-Yu Weng (Jianyu Weng, JianYu Weng)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Acute Myeloid Leukemia

Transforming Growth Factor

Mesenchymal Stem Cells

Top Venues

Clinical and translational science

Molecular medicine (Cambridge, Mass.)

Turkish journal of haematology : official journal of Turkish Society of Haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Qian Wang, Ling-Ji Zeng, Man Wang, Jian-Yu Weng, Jin-Lan Pan
Identification of a Novel MAPK1::BCR Fusion Gene/t(9;22) (q34;q11) in a Case of Acute Promyelocytic Leukemia Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (3) (2024)
Chao Li, ChengXin Deng, Ping Wu, KaiFan Liu, Xin Huang, MingMin Li, XiaoMei Chen, SuXia Geng, PeiLong Lai, Jian-Yu Weng, Xin Du
Outcomes of intermediate or high-risk CMML patients treated with hypomethylating agents combined with venetoclax: A single center experience. Clinical and translational science 17 (1) (2024)
Chao Li, ChengXin Deng, Ping Wu, KaiFan Liu, Xin Huang, MingMin Li, XiaoMei Chen, SuXia Geng, PeiLong Lai, Jian-Yu Weng, Xin Du
Outcomes of intermediate or high-risk CMML patients treated with hypomethylating agents combined with venetoclax: A single center experience. Clinical and translational science 17 (1) (2024)
Ruohao Xu, Miao Wu, Yawen Wang, Chao Li, Lingji Zeng, Yulian Wang, Maozhi Xiao, Xiaomei Chen, Suxia Geng, Peilong Lai, Xin Du, Jian-Yu Weng
Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Chao Li, ChengXin Deng, Ping Wu, KaiFan Liu, Xin Huang, MingMin Li, XiaoMei Chen, SuXia Geng, PeiLong Lai, Jian-Yu Weng, Xin Du
Outcomes of intermediate or high-risk CMML patients treated with HMAs combined with Venetoclax: a single center experience. Clinical and translational science (2023)
Chao Li, ChengXin Deng, Ping Wu, KaiFan Liu, Xin Huang, MingMin Li, XiaoMei Chen, SuXia Geng, PeiLong Lai, Jian-Yu Weng, Xin Du
Outcomes of intermediate or high-risk CMML patients treated with HMAs combined with Venetoclax: a single center experience. Clinical and translational science (2023)
Xiao-Shuai Zhang, Robert Peter Gale, Bingcheng Liu, Jian Huang, Yanli Zhang, Xin Du, Jian-Yu Weng, Weiming Li, Na Xu, Xiaoli Liu, Chunyan Chen, Hai Lin, Guohui Li, Rong Liang, Zhuogang Liu, Xiaodong Wang, Yanqing Zhang, Yanqiu Han, Chunshui Liu, Jian-da Hu, Lie Lin, Wei Yang, Zhenfang Liu, Li Meng, Chuanqing Tu, Caifeng Zheng, Zeping Zhou, Yanliang Bai, Huiying Qiu, Suning Chen, Fei Li, Jianxin Guo, Zelin Liu, Hui Sun, Li Zhou, Ru Feng, Xiuli Sun, Xiao-Jun Huang, Qian Jiang
Validation of the imatinib-therapy failure model. Leukemia (2023)
Chao Li, ChengXin Deng, Ping Wu, KaiFan Liu, Xin Huang, MingMin Li, XiaoMei Chen, SuXia Geng, PeiLong Lai, Jian-Yu Weng, Xin Du
Outcomes of intermediate or high-risk CMML patients treated with HMAs combined with Venetoclax: a single center experience. Clinical and translational science (2023)
Ruohao Xu, Miao Wu, Yawen Wang, Chao Li, Lingji Zeng, Yulian Wang, Maozhi Xiao, Xiaomei Chen, Suxia Geng, Peilong Lai, Xin Du, Jian-Yu Weng
Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Ruohao Xu, Miao Wu, Yawen Wang, Chao Li, Lingji Zeng, Yulian Wang, Maozhi Xiao, Xiaomei Chen, Suxia Geng, Peilong Lai, Xin Du, Jian-Yu Weng
Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Ruohao Xu, Miao Wu, Yawen Wang, Chao Li, Lingji Zeng, Yulian Wang, Maozhi Xiao, Xiaomei Chen, Suxia Geng, Peilong Lai, Xin Du, Jian-Yu Weng
Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Jinghua Wang, Weida Wang, Hao Chen, Wenmin Li, Tian Huang, Weiya Zhang, Wei Ling, Peilong Lai, Yulian Wang, Suxia Geng, Minming Li, Xin Du, Jian-Yu Weng
C-Type Lectin-Like Molecule-1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study. BioMed research international 2021 (2021)
Zhenzhen Xu, Chengwei Luo, Peilong Lai, Wei Ling, Suijing Wu, Xin Huang, Lisi Huang, Guanrong Zhang, Xin Du, Jian-Yu Weng
von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 26 (2020)